Clinically, we have experienced a specific group of patients whose diagnoses changed from unipolar depression to bipolar disorder, and finally to dementia. In this short review, we propose a hypothesis that a genetic glycogen synthase kinase-3 (GSK-3) abnormality may be a common etiological factor in these diseases and in diagnostic conversions.
| DEPRE SS I ON TO B IP OL AR D ISORDERA substantial portion of patients with unipolar depression experience diagnostic conversion to bipolar disorder. For example, of 72 patients diagnosed with depression at the mean age of 10.3 years, 48.6% of patients developed bipolar disorder during the subsequent 10 years. 1 Further, of 91,587 patients with depression at the mean age of 31 years, 8.4% of patients developed bipolar disorder over the 20-year follow-up period. 2 Therefore, the younger the age at which depression occurs, the more likely that depression is to be diagnosed as bipolar depression (ie, depressive episode of bipolar disorder) rather than unipolar depression. A similar observation has been noted, in that a younger age at diagnosis of depression predicted increased conversion to bipolar disorder (hazard ratio = 0.98, 95% CI: 0.97-0.98). 3 A meta-analysis 4 reported that the cumulative risk of conversion during a 10-year observation period was 12.9% using data from 11 studies, and 14.7% using data from nine studies excluding those of two register-based studies.
AbstractObjectives: To focus on a specific group of patients whose diagnoses were changed from unipolar depression to bipolar disorder, and finally to dementia.Methods: Qualitative review of the relevant articles.